Harnessing the small intestinal axis to resolve systemic inflammation
- PMID: 36458009
- PMCID: PMC9706197
- DOI: 10.3389/fimmu.2022.1060607
Harnessing the small intestinal axis to resolve systemic inflammation
Abstract
This Perspective presents the potential of the Small Intestinal Axis, a sub-division of the Gut-immune Axis, to modulate systemic inflammation based on sensing contents of the gut lumen. Gut mucosal immunity regulates tolerance to food and gut contents and is a significant factor in maintaining systemic homeostasis without compromising immunity to pathogens. This is achieved through anatomical structures and signaling pathways that link the tolerogenic potential of the proximal small intestine to systemic immunity. Non-live preparations of microbes isolated from human small intestinal mucosa, and the extracellular vesicles (EVs) which they shed, can resolve systemic inflammation without systemic exposure after oral delivery. The mechanism involves primary interactions with pattern recognition receptors followed by trafficking of immune cells through mesenteric lymph nodes. This generates in the periphery a population of circulating CD4+ T cells which have regulatory function but an atypical FoxP3- phenotype. There is no modification of the resident gut microbiome. Discoveries using this novel approach of targeting mucosal microbial elements to the tolerogenic proximal regions of the small intestine are revealing some of the mysteries of the relationship between the gut and immune system.
Keywords: T-cell; immunity; medicines; mucosa; oral tolerance; small intestine.
Copyright © 2022 Bodmer, Itano and McInnes.
Conflict of interest statement
MB and AI are employees of Evelo Biosciences Inc. IM is a non-executive member of the Board of Directors of the company. Authors MB and AI declare that this study received funding from Evelo Biosciences Inc. The funder was involved in the study design, collection, analysis, interpretation of data, and the decision to submit it for publication.
Figures
Similar articles
-
Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity.Viruses. 2018 Mar 23;10(4):146. doi: 10.3390/v10040146. Viruses. 2018. PMID: 29570694 Free PMC article. Review.
-
Regulatory effects of oral microbe on intestinal microbiota and the illness.Front Cell Infect Microbiol. 2023 Feb 1;13:1093967. doi: 10.3389/fcimb.2023.1093967. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36816583 Free PMC article. Review.
-
The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.Neurogastroenterol Motil. 2016 Apr;28(4):463-86. doi: 10.1111/nmo.12717. Epub 2015 Nov 11. Neurogastroenterol Motil. 2016. PMID: 26556786 Review.
-
Pulmonary Aspergillus fumigatus infection in rats affects gastrointestinal homeostasis.Immunobiology. 2019 Jan;224(1):116-123. doi: 10.1016/j.imbio.2018.10.001. Epub 2018 Oct 13. Immunobiology. 2019. PMID: 30348457
-
Regulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal Bacteria.Front Immunol. 2022 Feb 2;13:768076. doi: 10.3389/fimmu.2022.768076. eCollection 2022. Front Immunol. 2022. PMID: 35185874 Free PMC article.
Cited by
-
Genetic heterogeneity of colorectal cancer and the microbiome.World J Gastrointest Oncol. 2023 Mar 15;15(3):443-463. doi: 10.4251/wjgo.v15.i3.443. World J Gastrointest Oncol. 2023. PMID: 37009315 Free PMC article. Review.
-
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.Noncoding RNA. 2025 Feb 13;11(1):16. doi: 10.3390/ncrna11010016. Noncoding RNA. 2025. PMID: 39997616 Free PMC article. Review.
-
Mucositis and Infection in Hematology Patients.Int J Mol Sci. 2023 May 31;24(11):9592. doi: 10.3390/ijms24119592. Int J Mol Sci. 2023. PMID: 37298545 Free PMC article.
-
Exploring the complex immunomodulatory effects and gut defense via oral administration of Astragali radix water extract to normal mice.BMC Complement Med Ther. 2024 Oct 7;24(1):361. doi: 10.1186/s12906-024-04667-z. BMC Complement Med Ther. 2024. PMID: 39375623 Free PMC article.
-
A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis.Front Med (Lausanne). 2024 May 15;11:1292406. doi: 10.3389/fmed.2024.1292406. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38813388 Free PMC article.
References
-
- Nunn JF. Ancient Egyptian medicine. Trans Med Soc Lond (1996) 113:57–68. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials